ResMed(RMD) - 2024 Q3 - Earnings Call Presentation

Operating Cash Flow ($M) Free Cash Flow ($M) $134.1$113.9 $109.0 LTM 3Q22 LTM 3Q23 LTM 3Q24$364.1 $421.5 LTM 3Q22 LTM 3Q23 LTM 3Q24 Total debt outstanding$1,007M Net Debt $769M (Financial data as of March 31, 2024) 16 © 2024 ResMed | Q3 2024 Earnings Presentation – Apr. 25, 2024 Capital deployed over last 3 years (through March 31, 2024) Reinvest for growth • Reinvest in product development for high-return organic growth • Pursue targets aligned with long-term strategic goals and financial objectives • R ...